A Phase 2 Randomized Trial of NBI-1065846 (TAK-041) in Patients With Anhedonia Associated With Major Depressive Disorder: Results of the TERPSIS Study
NBI-1065846 (TAK-041) 治疗伴有重度抑郁症的快感缺失患者的 II 期随机试验:TERPSIS 研究结果
期刊:Journal of Clinical Psychopharmacology
影响因子:2.8
doi:10.1097/JCP.0000000000002046
Benedetto, Shannon R; Ionescu, Adrian; Ge, Tingting; Furey, Maura; Lin, Swan; Jha, Manish K; Krystal, Andrew; Shah, Asim A; Walling, David P; Shah, Neel; Rizvi, Sakina J; Kennedy, Sidney; Laurenza, Antonio; Murthy, Venkatesha; Roberts, Eiry; Singh, Jaskaran B